Skinvisible, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.279296 million compared to USD 0.663426 million a year ago. Net loss was USD 1.22 million compared to USD 1.07 million a year ago.

Basic loss per share from continuing operations was USD 0.27 compared to USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 0.27 compared to USD 0.24 a year ago.